Perspective Therapeutics Inc. (NYSE AMERICAN: CATX) Stock Information | RedChip

Perspective Therapeutics Inc. (NYSE AMERICAN: CATX) Listen to this Section


$13.43
-0.5300 ( -3.80% ) 746.8K

Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.

Market Data


Insider Ownership Transactions

Total Amount Purchased: -690,000.00 | $ -9,266,700.00

Date Type Amount Purchased Purchaser
2023-12-14 Sale -230000.00 Williamson Robert F III
2023-12-14 Sale -230000.00 HENSON HEIDI
2023-12-14 Sale -230000.00 Woods Lori A

SEC Fillings


Form Type Description Pages Date
pre Proxies and info statements 5 Apr 08, 2024
8-k 8K-related 12 Apr 08, 2024
8-k 8K-related 15 Apr 03, 2024
10-k Annual reports 124 Mar 28, 2024
8-k 8K-related 16 Mar 28, 2024
8-k 8K-related 14 Mar 25, 2024
8-k 8K-related 117 Mar 19, 2024
8-k 8K-related 103 Mar 08, 2024
4 Insider transactions 1 Mar 08, 2024
8-k 8K-related 22 Mar 06, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.